“Efficacy and Clinical Outcomes of Remdesivir Plus Intravenous Cefepime Compared to Remdesivir Plus Intravenous Levofloxacin in Type 2 Diabetes Mellitus Iraqi Patients with COVID -19” (2022) Journal of Pharmaceutical Negative Results, 13(2), pp. 82–86. Available at: https://www.pnrjournal.com/index.php/home/article/view/199 (Accessed: 24 June 2026).